MA30475B1 - Acides biphenyl carboxyliques substitutes et derives en resultant. - Google Patents

Acides biphenyl carboxyliques substitutes et derives en resultant.

Info

Publication number
MA30475B1
MA30475B1 MA31395A MA31395A MA30475B1 MA 30475 B1 MA30475 B1 MA 30475B1 MA 31395 A MA31395 A MA 31395A MA 31395 A MA31395 A MA 31395A MA 30475 B1 MA30475 B1 MA 30475B1
Authority
MA
Morocco
Prior art keywords
derivatives
carboxylic acids
substituted biphenyl
biphenyl carboxylic
compounds
Prior art date
Application number
MA31395A
Other languages
English (en)
Inventor
Francis Wilson
Alison Reid
Valerie Reader
Richard John Harrison
Mihiro Sunose
Remedios Hernadez-Perni
Jeremy Major
Cyrille Boussard
Kathryn Smelt
Jess Taylor
Adeline Leformal
Andrew Cansfield
Svenja Burckhardt
Chih Yung Ho
Yan Zhang
Original Assignee
Ortho Mcneil Pharm Inc
Cellzome Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc, Cellzome Ltd filed Critical Ortho Mcneil Pharm Inc
Publication of MA30475B1 publication Critical patent/MA30475B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/42—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

La présente invention a pour objet des composés présentant la formule générale (I), les définitions de X, Y, R1,R.2, R3, R4 R9, et R10 données ci-dessous, et/ou un sel ou ester en dérivant. De plus la présente invention a pour objet l'emploi desdits composés pour le traitement de la maladie d'Alzheimer et leur emploi pour la modulation de l'activité de (gamma)-sécrétase.
MA31395A 2006-04-21 2008-11-20 Acides biphenyl carboxyliques substitutes et derives en resultant. MA30475B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06112938A EP1849762B1 (fr) 2006-04-21 2006-04-21 Acides biphényl carboxyliques substitués et leurs dérivés

Publications (1)

Publication Number Publication Date
MA30475B1 true MA30475B1 (fr) 2009-06-01

Family

ID=36688012

Family Applications (1)

Application Number Title Priority Date Filing Date
MA31395A MA30475B1 (fr) 2006-04-21 2008-11-20 Acides biphenyl carboxyliques substitutes et derives en resultant.

Country Status (35)

Country Link
US (1) US7557244B2 (fr)
EP (2) EP1849762B1 (fr)
JP (1) JP5479088B2 (fr)
KR (1) KR101542255B1 (fr)
CN (1) CN101687758B (fr)
AP (1) AP2008004656A0 (fr)
AR (1) AR060568A1 (fr)
AU (1) AU2007240335B2 (fr)
BR (1) BRPI0710656A2 (fr)
CA (1) CA2650006C (fr)
CR (2) CR10375A (fr)
CY (1) CY1109399T1 (fr)
DE (1) DE602006007810D1 (fr)
DK (1) DK1849762T3 (fr)
EA (1) EA016129B9 (fr)
ES (2) ES2328616T3 (fr)
GE (1) GEP20115269B (fr)
GT (1) GT200900120A (fr)
IL (2) IL194790A (fr)
MA (1) MA30475B1 (fr)
MX (1) MX2008013445A (fr)
MY (1) MY148953A (fr)
NO (1) NO20084517L (fr)
NZ (1) NZ573000A (fr)
PE (1) PE20080364A1 (fr)
PL (1) PL1849762T3 (fr)
PT (1) PT1849762E (fr)
SI (1) SI1849762T1 (fr)
SM (1) SMP200800061B (fr)
TN (1) TNSN08413A1 (fr)
TW (1) TWI399362B (fr)
UA (1) UA95952C2 (fr)
UY (1) UY30301A1 (fr)
WO (1) WO2007124394A1 (fr)
ZA (1) ZA200809856B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101618068B1 (ko) 2007-10-19 2016-05-04 얀센 파마슈티카 엔.브이. γ-세크레타아제의 탄소 결합된 조절제
WO2009052126A1 (fr) 2007-10-19 2009-04-23 Janssen Pharmaceutica, N.V. Modulateur de pipéridinyl et de pipérazinyl de la γ-secrétase
CN101903335A (zh) 2007-10-19 2010-12-01 詹森药业有限公司 连接有胺的γ-分泌酶调节剂
CN101903334A (zh) * 2007-10-19 2010-12-01 詹森药业有限公司 Gsm中间体
US20110092554A1 (en) * 2007-11-19 2011-04-21 Richard Chesworth 1,3,5 tri-subtituted benzenes for treatment of alzheimer's disease and other disorders
WO2009086277A1 (fr) 2007-12-20 2009-07-09 Envivo Pharmaceuticals, Inc. Benzènes tétrasubstitués
US8871796B2 (en) 2009-10-16 2014-10-28 Merck Sharp & Dohme Corp. Diaryl ether derivatives as notch sparing gamma secretase inhibitors
US8785481B2 (en) 2010-09-29 2014-07-22 Merck Sharp & Dohme Corp. Ether benzotriazole derivatives
CA2828764A1 (fr) * 2011-03-03 2012-09-07 Treventis Corporation Composes anti-amyloides et procedes
WO2015109109A1 (fr) 2014-01-15 2015-07-23 Forum Pharmaceuticals Inc. Morpholino-pyrimidines fusionnées et leurs procédés d'utilisation
WO2016201168A1 (fr) 2015-06-10 2016-12-15 Forum Pharmceuticals Inc. Composés oxadiazine et leurs méthodes d'utilisation

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5877399A (en) * 1994-01-27 1999-03-02 Johns Hopkins University Transgenic mice expressing APP-Swedish mutation develop progressive neurologic disease
JP3802581B2 (ja) * 1995-03-01 2006-07-26 富山化学工業株式会社 新規なビフェニル誘導体またはその塩およびそれらを含有する抗炎症剤
JP2003530437A (ja) * 2000-04-13 2003-10-14 マヨ ファウンデーション フォー メディカル エデュケーション アンド リサーチ Ａβ４２低下物質
DE10131899A1 (de) 2001-07-04 2003-02-27 Boehringer Ingelheim Pharma In vitro-Screening-Assay für gamma-Secretase
KR100693367B1 (ko) * 2002-06-27 2007-03-12 아스텔라스세이야쿠 가부시키가이샤 아미노알콜 유도체
GB0305918D0 (en) * 2003-03-14 2003-04-23 Glaxo Group Ltd Novel compounds
WO2005110963A1 (fr) * 2004-05-19 2005-11-24 Cellzome Ag Acides (biphenyl-3-yl)-carboxyliques et derives de ceux-ci ainsi que leur utilisation en therapie
GB0416508D0 (en) * 2004-07-23 2004-08-25 Merck Sharp & Dohme Therapeutic agents
WO2006022237A1 (fr) * 2004-08-24 2006-03-02 Kissei Pharmaceutical Co., Ltd. Médicament servant à prévenir ou à traiter la stéatose hépatique
EP1937632A1 (fr) * 2005-10-06 2008-07-02 Astra Zeneca AB Nouveaux composes

Also Published As

Publication number Publication date
PT1849762E (pt) 2009-09-16
MX2008013445A (es) 2009-03-10
EP1849762A1 (fr) 2007-10-31
MY148953A (en) 2013-06-14
AP2008004656A0 (en) 2008-10-31
ES2400530T3 (es) 2013-04-10
SMP200800061B (it) 2009-07-14
KR101542255B1 (ko) 2015-08-06
SI1849762T1 (sl) 2009-12-31
EP2021314A1 (fr) 2009-02-11
GT200900120A (es) 2009-11-16
CR10451A (es) 2009-03-31
CN101687758B (zh) 2014-05-14
UA95952C2 (ru) 2011-09-26
PE20080364A1 (es) 2008-05-16
JP5479088B2 (ja) 2014-04-23
AR060568A1 (es) 2008-06-25
EP2021314B1 (fr) 2013-01-23
AU2007240335B2 (en) 2013-05-02
EP1849762B1 (fr) 2009-07-15
AU2007240335A1 (en) 2007-11-01
ZA200809856B (en) 2009-06-24
EA016129B1 (ru) 2012-02-28
SMAP200800061A (it) 2008-11-19
CY1109399T1 (el) 2014-07-02
TW200815320A (en) 2008-04-01
KR20090024679A (ko) 2009-03-09
IL194790A (en) 2012-12-31
CN101687758A (zh) 2010-03-31
NO20084517L (no) 2009-01-13
US7557244B2 (en) 2009-07-07
IL194852A0 (en) 2009-08-03
ES2328616T3 (es) 2009-11-16
JP2009544573A (ja) 2009-12-17
CR10375A (es) 2009-02-26
US20070293567A1 (en) 2007-12-20
UY30301A1 (es) 2007-08-31
DK1849762T3 (da) 2009-10-12
TNSN08413A1 (en) 2010-04-14
WO2007124394A1 (fr) 2007-11-01
PL1849762T3 (pl) 2009-12-31
GEP20115269B (en) 2011-08-25
CA2650006A1 (fr) 2007-11-01
TWI399362B (zh) 2013-06-21
CA2650006C (fr) 2016-08-23
BRPI0710656A2 (pt) 2011-08-16
IL194790A0 (en) 2009-08-03
DE602006007810D1 (de) 2009-08-27
EA200802172A1 (ru) 2009-06-30
EA016129B9 (ru) 2012-06-29
NZ573000A (en) 2011-11-25

Similar Documents

Publication Publication Date Title
MA30475B1 (fr) Acides biphenyl carboxyliques substitutes et derives en resultant.
MA29514B1 (fr) Acides carboxylique (biphenyle) et leurs derives
ATE343388T1 (de) Pde-v hemmer zur behandlung von morbus parkinson
MA27472A1 (fr) Acetyle 2-hydroxy-1, 3 diaminoalcanes
EP1689713A4 (fr) Inhibiteurs de benzylether et benzylamino de beta-secretase pour traiter la maladie d'alzheimer
MA30420B1 (fr) Derives de terphenyle pour le traitment de la maladie d'alzheimer
EP1673078A4 (fr) Inhibiteurs de type benzylether et benzylamino de beta-secretase pour le traitement de la maladie d'alzheimer
PE20121640A1 (es) Derivados de pirazina como inhibidores de bace
ATE506951T1 (de) Als inhibitoren von beta-secretase aktive tertiäre carbinamine mit substituierten heterocyclen zur behandlung der alzheimer- krankheit
EP2091328A4 (fr) Composés de spiropipéridine inhibiteurs de la bêta-sécrétase pour le traitement de la maladie d'alzheimer
MA30402B1 (fr) Acides carboxyliques substitues par des phenylamino-benzoxazoles, leur procede de production et leur utilisation comme medicaments
EA200802054A1 (ru) Ингибиторы фермента
EA201000884A1 (ru) Производные 1,2-дизамещенного 4-бензиламинопирролидина в качестве ингибиторов белка-переносчика холестерилового эфира, используемые для лечения заболеваний, таких как гиперлипидемия или артериосклероз
ATE440087T1 (de) 2,4-diaminopyrimidinderivate, die sich als inhibitoren von pkc-theta eignen
EA200601660A1 (ru) Ингибирующие mtp арилпиперидины или пиперазины, замещенные 5-членными гетероциклами
CY1111070T1 (el) Παραγωγα 2-αμινο-κουιναζολινης χρησιμα ως αναστολεις της β-σεκρετασης (bace)
DE60326232D1 (de) Verwendung von substituierten cyanopyrrolidinen zur behandlung von hyperlipidämie
MA31742B1 (fr) Derives de l'indol-2-one disubstitues en 3, leur preparation et leur application en therapeutique
EP1817312A4 (fr) Inhibiteurs de l'aminopyridyle de la beta-secretase macrocyclique permettant de traiter la maladie d'alzheimer
ATE538796T1 (de) Piperidin- und pyrrolidin-beta-secretase-hemmer zur behandlung von alzheimer-krankheit
MXPA06013503A (es) Uso de compuestos de kaureno en la manufactura de medicamentos.
MA28562B1 (fr) 1,3,4-oxadiazol-2-ones comme modulateurs de ppar delta et leur utilisation
TNSN08138A1 (fr) Derives d'imidazole pour le traitement de troubles neurologiques
EP2073635A4 (fr) Inhibiteurs de spiropipéridine macrocyclique de bêta-secrétase pour le traitement de la maladie d'alzheimer
ATE432262T1 (de) Pyrazolphenylderivate als ppar-aktivatoren